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Yusuf Haji1, Wakgari Deressa2*, Gail Davey3 and Andrew W Fogarty4Abstract
Background: Early diagnosis is important in preventing mortality from malaria. The hypothesis that guardians’ fear of
covert human immunodeficiency virus (HIV) testing delays presentation of children with suspected malaria was tested.
Methods: The study design is a cross-sectional survey. The study population consisted of guardians of children with
suspected malaria who presented to health centres in Oromia Region, Ethiopia. Data were collected on attitudes to HIV
testing and the duration of children’s symptoms using interview administered questionnaires.
Results: Some 830 individuals provided data representing a response rate of 99% of eligible participants. Of these, 423
(51%) guardians perceived that HIV testing was routinely done on blood donated for malaria diagnosis, and 353 (43%)
were aware of community members who delayed seeking medical advice because of these concerns. Children whose
guardians suspected that blood was covertly tested for HIV had longer median delay to presentation for evaluation
at health centres compared to those children whose guardians did not hold this belief (three days compared to two
days, p < 0.001). Children whose guardians were concerned about covert HIV testing were at a higher odds of a
prolonged delay before being seen at a health centre (odds ratio 1.73, 95% confidence intervals: 1.10 to 270 for a
delay of ≥3 days compared to those seen in ≤2 days).
Conclusion: Children whose guardians believed that covert testing for HIV was routine clinical practice presented later
for investigation of suspected malaria. This may account for up to 14% of the delay in presentation and represents a
reversible risk factor for suboptimal management of malaria.
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Malaria constitutes an important treatable cause of global
morbidity and mortality, with 3.4 billion people estimated
to be at risk of infection in 2012, resulting in approximately
200 million cases of malarial infection and 600,000 deaths,
predominantly in young children [1]. Malaria is one of the
most important public health problems in Ethiopia, repre-
senting the commonest communicable disease and ac-
counting for 30% of the overall disability adjusted life years
lost [2] as well as imposing a high economic cost [3]. As
malaria can be diagnosed using laboratory assays and effect-
ive treatments exist for malaria [4], the national malaria
control programme states the importance of improving* Correspondence: deressaw@gmail.com
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unless otherwise stated.treatment-seeking behaviour for fever [2]. However, intro-
ducing diagnostic algorithms that involve new rapid diag-
nostic blood tests for malaria can be problematic [5],
although delayed presentation is a substantial problem in
treating malaria [6-8], and the identification of any barriers
that impede presentation at health care facilities is a priority
area of research as these may be amenable to intervention.
The prevalence of human immunodeficiency virus (HIV)
infection in Ethiopia in 2011 was estimated to be 4.2% in
urban areas and 0.6% in rural areas [9]. There is a stigma
associated with HIV infection [10-12], and 25% of pregnant
women in Gambella region refused antenatal HIV testing
in 2008 [13]. Hence, despite the availability of treatment, in-
dividuals may be reluctant to undergo testing of their HIV
status, as they do not wish to be exposed to the knowledge
and social consequences of a potential positive diagnosis.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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requesting an HIV test on any blood sample, there may
be a perception that having a blood test for malaria is
synonymous with being tested for HIV infection, as pre-
viously reported in qualitative studies elsewhere [14-16].
This is important, as it is a perception that is open to
modification by appropriate educational programmes,
hence improving the early delivery of appropriate anti-
malarial treatments to patients. Hypothesizing that indi-
viduals’ concerns about covert HIV testing is impeding
presentation of symptomatic children for investigation
and treatment for malaria, a cross-sectional observational
study design in Ethiopia to test this hypothesis in children
with suspected malaria visiting health centres.
Methods
Study population
The study design is a cross-sectional survey. This study
was conducted in East Shewa Zone of Oromia Regional
State in Ethiopia. The total population of the Zone in
2010/11, as projected based on the 2007 census, was
1,519,103 (51% males and 49% females). The Zone is
located in the Great Rift Valley of East Africa and malaria
is a major health problem in the area. Five health centres,
namely Modjo, Meki, Batu, Bulbula, and Shashemenne,
were included in the study and data were collected in
October and November 2012. All children under the
age of 16 years who presented with symptoms consistent
with malaria and gave finger-prick blood for microscopic
examination at the health centres and their guardians
constituted the study population. Data were collected
opportunistically, when the guardian was available for inter-
view. The study protocol was approved by the University
of Nottingham Ethics Committee and the Addis Ababa
University School of Public Health Research and Ethics
Committee. All participants gave informed consent and
received standard treatment for their presenting condition.
Data collection
A pre-tested structured questionnaire initially developed
in English and then back translated into local language
(Afan Oromo) was used for data collection (see Additional
files 1 and 2). The main sections of the questionnaire
comprised of sociodemographic characteristics, concerns
about HIV testing and treatment-seeking behaviour for
the sick child. One data collector and one supervisor
from each health centre were trained on the data collection
instrument, interview techniques and recruitment of the
study participants. Subsequent diagnosis of malaria was
done using blood film examination under microscopy.
Statistical analysis and power calculation
All completed data collection forms were examined for
completeness and consistency during data management,storage and analysis. The time between the onset of
symptoms suggestive of malaria to presentation to the
health centre was the primary outcome. The main exposure
of interest was the response to the question ‘do you think
that HIV testing is done for all people who give blood
samples for malaria testing at the heath facility?’ During
analysis, the outcome variable was categorized into
‘early’ (≤2 days) and ‘late’ (≤3 days) as used in previous
studies of this topic [7,17-19] and also as categorization
using this cut-off approximated to the median value. Initial
analysis was by chi-squared testing and subsequent analysis
by logistic regression adjusting for potential confounding
factors and clustering by health centre. The impact of
urban and rural locations on the primary exposure was
explored as the prevalence of HIV infection varied between
these settings. All demographic exposures of interest were
considered as potential confounding factors if they modi-
fied the size of association between the primary outcome
and the exposure by 10% or more. The population attribut-
able fraction of the impact of the associations observed at
the population level was calculated after converting odds
ratios (ORs) to relative risks (RRs) [20,21].
The aim was to recruit 850 individuals. All children
under the age of 16 years who presented at the health
centre with their guardian and were clinically suspected
of potentially having malaria (defined as having a blood
film test requested) were eligible for inclusion in the
study. The total sample size allocated to each health
centre was proportional to the total patients tested for
malaria in the previous 3 months (June-August, 2012)
and individuals were recruited consecutively until the
estimated sample size was achieved. Assuming that 20%
of guardians had concerns about HIV testing in popula-
tion and 50% of children have had symptoms for 5 days
or less, it was estimated that the study would have over
90% power (5% risk of type I error) to detect an absolute
increase of 20% in the guardians who had concerns
about HIV testing in the children who experienced mal-
aria symptoms for five days or more compared to those
whose guardians had no such concerns.
Role of the funding source
The sponsors of the study had no role in study design,
data collection, data analysis, data interpretation, or
writing of the report. The corresponding author had full
access to the data in the study and had full responsibility
for the decision to submit.
Results
Study demographics
A total of 836 guardians were invited to participate in the
study and of these, 830 (99%) provided data for analysis.
The demographics of the study participants are reported
in Table 1. Some 400 children (48%) were reported as
Table 1 Demographic characteristics of guardians
Total Concern about covert HIV testing
(%) N = 830 Yes (%) N = 423 No/do not know (%) N = 407 p value*
Location
Urban 469 (57) 226 (53) 243 (60) 0⋅07
Rural 361 (43) 197 (47) 164 (40)
Sex
Male 263 (32) 133 (31) 130 (32) 0.88
Female 567 (68) 290 (69) 277 (68)
Age (years)
16-24 157 (19) 81 (19) 76 (19) 0.54
25-34 382 (46) 203 (48) 179 (44)
35-44 231 (28) 112 (26) 119 (29)
44+ 60 (7) 27 (6) 33 (8)
Relationship to sick child
Mother 503 (61) 255 (60) 248 (61)
Father 213 (26) 104 (25) 109 (27) 0.60
Sibling 78 (9) 45 (11) 33 (8)
Other 36 (4) 19 (4) 17 (4)
Highest level of education
Illiterate 284 (34) 146 (35) 138 (34) 0.09
Literate but no formal education 69 (8) 30 (7) 39 (10)
Primary school 302 (36) 168 (40) 134 (33)
Secondary school or higher 175 (21) 79 (19) 96 (24)
Main material of household’s roof
Corrugated iron 614 (74) 306 (72) 308 (76) 0.27
Thatched 216 (26) 117 (28) 99 (24)
Electricity in household
Yes 507 (61) 250 (59) 257 (63) 0.23
No 323 (39) 173 (41) 150 (37)
Perceived walking time to nearest health centre (min)
<30 446 (54) 228 (54) 218 (54) 0.37
30-60 216 (26) 111 (26) 105 (26)
60-120 91 (11) 41 (10) 50 (12)
120-180 48 (6) 30 (7) 18 (4)
>180 29 (3) 13 (3) 16 (4)
*Chi-squared test.
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2 days, and 114 (14%) had sought health advice prior to
the current presentation (Table 2). The overall prevalence
of malaria was 20% for participants in the study, and the
prevalence for each health centre was Modjo (12%), Meki
(34%), Batu (18), Bulbula (15%), and Shashemenne (18%).
Concerns about HIV testing
Four-hundred and twenty-three (51%) individuals consid-
ered that HIV testing was applied to blood given formalaria testing at the health centre (Table 3); 353 (42%)
individuals knew of people in the community who delayed
seeking healthcare for malaria testing due to concerns
about HIV testing; 242 (29%) of individuals considered that
fear of HIV testing delayed presentation with suspected
malaria, with a higher proportion of these, 160 individuals
(34%), living in an urban environment compared to 82
participants (23%) who lived in a rural setting (p < 0.001).
Children whose guardians suspected that blood pro-
vided for malaria diagnosis was covertly tested for HIV
Table 2 Details of child and history of suspected malarial symptoms
Total Location
Urban Rural p value*
Median age of child (IQR) 6 (2–9) 5 (2–9) 6 (3–9) -
Sex of child (%) -
Male 423 (51) 248 (53) 175 (48)
Female 407 (49) 221 (47) 186 (52)
Number of days of illness prior to health centre attendance
<1 132 (16) 103 (22) 29 (8) <0.001
1 66 (8) 41 (9) 25 (7)
2 232 (28) 122 (26) 110 (34)
3 236 (28) 124 (26) 112 (31)
4 or more 164 (20) 79 (17) 85 (24)
Main reason for delayed attendance N = 626, (%)
Usually wait and see 187 (30) 107 (33) 80 (26) <0.001
Not serious illness 174 (28) 103 (32) 71 (23)
Lack of money 139 (22) 56 (17) 83 (27)
No nearby health facility 47 (8) 8 (2) 39 (13)
Fear of HIV testing 37 (6) 20 (6) 17 (6)
Other 42 (7) 27 (8) 15 (5)
Sought health advice prior to visiting current health centre (%)
Yes 114 (14) 52 (11) 62 (17) 0.01
No 716 (86) 417 (89) 299 (83)
Place of advice sought, N = 114, (%)
Health post/centre 59 (52) 9 (17) 50 (81) <0.001
Private clinic 44 (39) 35 (67) 9 (15)
Pharmacy 10 (9) 8 (15) 2 (3)
Other 1 (1) 0 (0) 1 (2)
*Chi-squared test.
IQR = interquartile range.
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symptoms to clinical evaluation compared to a median
of two days for those children whose guardians did not
hold this belief (p < 0.001). After adjustment for cluster-
ing by health centre, those children whose guardians
were concerned about covert HIV testing had a higher
odds of a prolonged delay before being seen at a health
centre (OR 1.73, 95% CI: 1.10 to 2.70 for a delay of more
than twp days). The age and sex of the child, residence,
age of the guardian, main material of the household’s
roof, presence of electricity, time to travel to the health
centre and health centre location were not confounding
factors for this association between HIV beliefs and a
delay in presentation with suspected malaria. This resulted
in a population attributable fraction for the association of
concerns about covert HIV testing on delayed presenta-
tion with malarial symptoms in children of 14% (95% CI:
3 to 23%).Discussion
This is the first study to specifically assess the impact of
concerns about HIV testing on the time to attendance at
a health centre among children with suspected malaria.
The data demonstrate that in this population, over half of
guardians of children with suspected malaria considered
that HIV testing was implemented on all blood donated
for malaria testing and that 43% of respondents knew of
others in their community who had delayed seeking med-
ical care because of these concerns. These beliefs appear
to impact not only on the individual, but their children as
guardians who were concerned about HIV testing were
more likely to bring their children for medical assessment
later than those who had no such concerns.
Methodological considerations and limitations
The study has a number of strengths including the pro-
spective assessment of an a priori hypothesis from a
Table 3 Health beliefs of guardians
Total Home
location
(%) Urban Rural p value*
Has opinion that HIV testing
is done for all people who
give blood for malaria
testing at heath facility
Yes 423 (51) 226 (48) 197 (55) 0.17
No 351 (42) 208 (44) 143 (40)
Do not know 56 (7) 35 (7) 21 (6)
Confidence that HIV testing
is done on blood given for
malaria testing
Not at all/little sure 370 (45) 219 (47) 151 (42) 0.18
Somewhat sure 129 (16) 62 (13) 67 (19)
Very/completely sure 295 (36) 168 (36) 127 (35)
Do not know 36 (4) 20 (4) 16 (4)
Aware of person in community
who did not attend health
facility for malaria testing
due to fear of HIV test
Yes 353 (43) 194 (41) 159 (44) 0.23
No 371 (45) 207 (44) 164 (45)
Do not know 106 (13) 68 (14) 38 (11)
Do you think that the fear of
HIV testing is the reason for
the delay in people seeking
an early diagnosis of malaria
at health facility?
Yes 242 (29) 160 (34) 82 (23) <0.001
No 386 (47) 192 (41) 194 (54)
Do not know 202 (24) 117 (25) 85 (24)
*Chi-squared test.
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malaria, who had no knowledge of the hypothesis being
tested. The response rate was high at 99%, giving confi-
dence in the generalizability of the findings to this
population and the minimization of bias, and data were
collected on co-variates permitting adjustment for other
demographic factors that may have been important.
The main limitation of these data is that while they
may be generalizable to the community studied during
the period of high malarial prevalence, these attitudes to
HIV testing and accessing health care in general are not
necessarily applicable to other communities and cultures
or at other times of the year. Hence, further studies are
required to determine how prevalent the belief that
covert HIV testing may accompany testing for malaria
actually is in the many countries with a high prevalence
of HIV. A delay of over two days before obtaining medical
assessment after symptoms of suspected malaria started
was seen in 49% of the study population, and similardelays have been observed from other observational
studies from Nigeria [22], Senegal [23], Ethiopia [7,24]
and India [19,25]. The estimates that these data provide
of the impact of fear of covert HIV testing necessarily
do not include those who died before presentation with
malaria, and hence may potentially underestimate the
overall impact of these beliefs on time to presentation.
The data are cross-sectional, and hence it is not possible
to demonstrate a causal effect. The authors were unable
to exclude the possibility that acquiescence bias (an
increased tendency to respond affirmatively to closed
questions [26]) may have influenced the data, and await
future studies that explore these beliefs and their impact
on healthcare seeking behaviour in similar populations.
Population-based cohort studies are necessary to study
these hypotheses prospectively with consideration of
baseline attitudes to HIV testing and observation of
subsequent medical consultation rates. These should
consider a broader range of diseases than just malaria
as it is possible that these observations may reflect a
wider mistrust of clinical care services that is delaying
presentation of patients with other treatable conditions.
The prevalence of refusal for HIV testing among women
attending for antenatal care in the Gambella Region of
Ethiopia in 2008 is 25%, suggesting that in this population
there was a sizeable minority who did not want to be
aware of their HIV status [13]. The data suggest that these
beliefs are adversely impacting on the presentation of chil-
dren with suspected malaria for medical attention, due to
the misplaced belief that they will also be tested for HIV.
Surprisingly, little data exist on how attitudes to HIV may
impact on presentation with potential malaria. Data from
rural Côte d’Ivoire collected from 2010 of 100 individuals
who were offered a rapid diagnostic testing for malaria
reported that 67% considered that the blood would be
used for HIV testing [27]. The only further data available
are from two separate qualitative studies exploring the
feasibility of introducing rapid diagnostic tests for malaria
in Uganda in a variety of settings. In one qualitative study,
community members expressed concern that blood
samples collected for malaria could be used for HIV
testing rather than malaria [15], which was similar to
the belief held by 51% of the study population. In the
second qualitative study, there were concerns that ‘in
most communities people think that taking of blood
means testing for HIV and some do not want their
HIV status disclosed’ [16].
Implications for policy
The observation that concerns about HIV testing may
delay malaria diagnosis in children is important for
public health policy makers as firstly malaria is a
common disease that infects approximately 200 million
individuals annually [1], and that secondly it is well
Haji et al. Malaria Journal 2014, 13:301 Page 6 of 7
http://www.malariajournal.com/content/13/1/301recognized that prompt diagnosis and treatment are
important to reduce morbidity and mortality [28-30].
As knowledge about the disease is amenable to public
education programmes [31,32], delayed presentation
with suspected malaria by the erroneous concern that
covert HIV testing may also be performed may be con-
sidered a risk environmental factor that is amenable to
educational programmes. If this association was causal,
the OR of 1.73 approximates to a rate ratio of 1.32
[20,21], giving a population attributable risk fraction
for the fear of covert HIV testing resulting in delayed
presentation of 14% children with malarial symptoms.
Conclusions
These data are consistent with the hypothesis that guard-
ians’ concerns about covert HIV testing without informed
consent is an independent risk factor for delayed pres-
entation to health centres for children with suspected
malaria. This is important, as it is a belief that is open
to modification by appropriate intervention programmes,
hence improving the early delivery of appropriate anti-
malarial treatments to patients and hence improving
clinical outcomes.
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